G&S Capital’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
CS
DCP
G&S Capital's NVCR Position: Q2 2020 in Review
G&S Capital sold out of NovoCure (NVCR) in Q2 2020, closing a stake of 200 shares — an estimated $13K sold.
G&S Capital first reported a position in NVCR in Q1 2019 and held it in 5 quarters. The position peaked at $16K in Q4 2019. 264 funds tracked by Wall St. Rank hold NVCR as of Q2 2020.
- G&S Capital reported no remaining NovoCure position as of Q2 2020 after selling out during the quarter.
- G&S Capital sold 200 NovoCure shares in Q2 2020, an estimated $13K.
- G&S Capital first reported a position in NovoCure in Q1 2019 and held it in 5 quarters.
- G&S Capital's NovoCure position peaked at $16K in Q4 2019.
- 264 funds tracked by Wall St. Rank held NovoCure as of Q2 2020.
Based on G&S Capital's 13F filing for Q2 2020, filed 24 Jul 2020.